AXIL Announces Sales Representative Agreement with Fuel Medical Group
AXIL Brands, Inc. (NYSE American: AXIL) has announced a non-exclusive sales representative agreement with Fuel Medical Group, a leading business advisory company for audiology and ENT practices. Under this agreement, Fuel will sell and promote AXIL's hearing performance product line through its affiliated network.
The partnership will make AXIL products available on various platforms, with affiliates benefiting from Fuel's practice support benefits. This collaboration aims to expand AXIL's presence in the commercial market by leveraging Fuel's national presence and strategic footprint. Fuel's network includes over 3000 affiliated locations, which will now have access to AXIL's product line of hearing protection.
AXIL Brands, Inc. (NYSE American: AXIL) ha annunciato un accordo di rappresentanza commerciale non esclusivo con Fuel Medical Group, una rinomata azienda di consulenza per le pratiche audiologiche e ENT. In base a questo accordo, Fuel venderà e promuoverà la linea di prodotti per le prestazioni uditive di AXIL attraverso la sua rete affiliata.
Questa partnership renderà i prodotti AXIL disponibili su varie piattaforme, con gli affiliati che beneficeranno del supporto pratico fornito da Fuel. Questa collaborazione mira a espandere la presenza di AXIL nel mercato commerciale sfruttando la presenza nazionale e l'impronta strategica di Fuel. La rete di Fuel comprende oltre 3000 sedi affiliate, che ora avranno accesso alla gamma di prodotti di protezione uditiva di AXIL.
AXIL Brands, Inc. (NYSE American: AXIL) ha anunciado un acuerdo de representación comercial no exclusivo con Fuel Medical Group, una destacada empresa de asesoría para prácticas de audiología y ENT. Según este acuerdo, Fuel venderá y promocionará la línea de productos de rendimiento auditivo de AXIL a través de su red afiliada.
La asociación hará que los productos de AXIL estén disponibles en varias plataformas, beneficiando a los afiliados de los beneficios de soporte de prácticas de Fuel. Esta colaboración tiene como objetivo ampliar la presencia de AXIL en el mercado comercial aprovechando la presencia nacional y la huella estratégica de Fuel. La red de Fuel incluye más de 3000 ubicaciones afiliadas, que ahora tendrán acceso a la línea de productos de protección auditiva de AXIL.
AXIL Brands, Inc. (NYSE American: AXIL)은 오디오로지 및 ENT 실습을 위한 선도적 비즈니스 자문 회사인 Fuel Medical Group과 비독점 판매 대리 협약을 체결했다고 발표했습니다. 이 협약에 따라 Fuel은 AXIL의 청각 성능 제품 라인을 판매 및 홍보합니다.
이 파트너십을 통해 AXIL 제품은 다양한 플랫폼에서 제공되며, 제휴사들은 Fuel의 연습 지원 혜택을 누리게 됩니다. 이 협력은 Fuel의 국가적 존재와 전략적 발판을 통해 AXIL의 상업적 시장 존재를 확장하는 것을 목표로 합니다. Fuel의 네트워크는 3000개 이상의 제휴 지점을 포함하고 있으며, 이들 지점은 이제 AXIL의 청각 보호 제품 라인에 접근할 수 있습니다.
AXIL Brands, Inc. (NYSE American: AXIL) a annoncé un accord de représentation commerciale non exclusif avec Fuel Medical Group, une entreprise de conseil de premier plan pour les pratiques d'audiologie et d'ORL. Dans le cadre de cet accord, Fuel va vendre et promouvoir la gamme de produits de performance auditive d'AXIL à travers son réseau affilié.
Ce partenariat rendra les produits AXIL disponibles sur diverses plateformes, les affiliés bénéficiant des avantages de soutien aux pratiques offerts par Fuel. Cette collaboration vise à étendre la présence d'AXIL sur le marché commercial en tirant parti de la présence nationale et de l'empreinte stratégique de Fuel. Le réseau de Fuel comprend plus de 3000 sites affiliés, qui auront désormais accès à la gamme de produits de protection auditive d'AXIL.
AXIL Brands, Inc. (NYSE American: AXIL) hat eine nicht-exklusive Vertriebsvereinbarung mit Fuel Medical Group bekannt gegeben, einem führenden Unternehmensberatungsunternehmen für Audiologie- und HNO-Praxen. Im Rahmen dieser Vereinbarung wird Fuel die Produktlinie von AXIL zur Hörverbesserung verkaufen und bewerben durch sein verbundenes Netzwerk.
Die Partnerschaft wird es ermöglichen, AXIL-Produkte auf verschiedenen Plattformen anzubieten, und die Affiliates profitieren von den Praxisunterstützungsleistungen von Fuel. Diese Zusammenarbeit zielt darauf ab, die Präsenz von AXIL auf dem kommerziellen Markt zu erweitern und die nationale Präsenz sowie die strategische Reichweite von Fuel zu nutzen. Das Netzwerk von Fuel umfasst über 3000 angeschlossene Standorte, die nun Zugang zur Produktlinie von AXIL zum Hörschutz haben.
- Non-exclusive sales representative agreement with Fuel Medical Group
- Expansion of AXIL's product offerings to the commercial market
- Access to Fuel's network of over 3000 affiliated locations
- Potential for increased sales and market presence
- None.
The partnership between AXIL Brands and Fuel Medical Group represents a strategic move in the hearing protection and enhancement market. This non-exclusive sales agreement has the potential to significantly expand AXIL's market reach, but its impact on the company's financials remains uncertain.
Key points to consider:
- Fuel Medical Group's network of over 3,000 affiliated locations provides AXIL with a substantial new distribution channel.
- The agreement covers AXIL's entire hearing performance product line, including popular models like GS Extreme 2.0®, XCOR® and the Trackr™ series.
- Fuel's practice support benefits, such as group purchasing and staff training, could enhance the appeal of AXIL products to healthcare providers.
However, investors should note:
- The agreement is non-exclusive, which may limit its long-term impact on AXIL's market position.
- No financial terms or sales targets were disclosed, making it difficult to quantify the potential revenue impact.
- The hearing protection market is competitive and AXIL's success will depend on product differentiation and effective marketing through Fuel's network.
While this partnership shows promise for expanding AXIL's commercial market presence, its true value will only become apparent as sales data emerges in future quarters. Investors should monitor upcoming financial reports for evidence of increased revenue and market penetration resulting from this collaboration.
The sales representative agreement between AXIL Brands and Fuel Medical Group presents an intriguing opportunity for AXIL, but its financial implications are not immediately clear. Here's a breakdown of the potential financial impact:
- Revenue Growth Potential: Access to Fuel's network of 3,000+ affiliated locations could significantly expand AXIL's customer base. However, without specific sales targets or commission structures, it's challenging to project the revenue uplift.
- Cost Considerations: While the agreement may boost sales, it could also impact AXIL's profit margins. Sales representative agreements typically involve commissions, which would be an additional cost for AXIL.
- Market Penetration: The partnership could accelerate AXIL's market penetration in the professional audiology and ENT sectors, potentially leading to increased brand recognition and long-term value.
- Inventory Management: AXIL may need to ramp up production to meet potential increased demand, which could impact short-term cash flow and inventory carrying costs.
Investors should look for updates in future earnings calls regarding:
- The rate of adoption among Fuel's affiliated practices
- Any changes in AXIL's cost structure related to this partnership
- Impact on overall sales growth and profit margins
While this agreement shows promise, its non-exclusive nature and lack of financial details make it difficult to assess its true value to AXIL's bottom line at this stage. Prudent investors will wait for concrete financial results before making investment decisions based on this news.
LOS ANGELES, July 31, 2024 (GLOBE NEWSWIRE) -- AXIL Brands, Inc. (“AXIL,” “we,” “us,” “our,” or the “Company”) (NYSE American: AXIL), an emerging global consumer products company for AXIL® hearing protection and enhancement products and Reviv3® hair and skin care products, today announced a non-exclusive sales representative agreement (“Agreement”) with Fuel Medical Group (“Fuel”), a leading business advisory company serving audiology, ear, nose and throat practices across the nation.
Under the Agreement, Fuel intends to sell and promote AXIL’s lineup of hearing performance product line, which includes GS Extreme 2.0®, XCOR®, XCOR Digital®, and the Trackr™ series hearing solutions through its affiliated network. AXIL products will be available in various platforms and affiliates will benefit from Fuel’s practice support benefits including group purchasing, strategy alignment, staff training and development.
“This relationship will further expand AXIL’s offerings to the commercial market by leveraging Fuel’s national presence and strategic footprint,” said Tyler Smith, National Director of Sales of AXIL Brands. “Fuel is an innovative market leader with a top-tier team, and we are extremely pleased to welcome them to our family of sales representative partnerships.”
“Fuel is happy to announce our partnership with Axil and give our more than 3000 affiliated locations access to Axil’s superior product line of hearing protection,” said Brendan Ford, co-founder of Fuel Medical Group.
About Fuel
As the leading business advisory company serving audiology and ear, nose and throat practices across the nation, Fuel Medical Group provides an award-winning array of custom insights, tools and actionable solutions that enhance practice performance and impact patient outcomes.
About AXIL
AXIL (NYSE American) is an emerging global consumer products company. The Company is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, under the AXIL® brand and premium hair and skincare products under its in-house Reviv3 Procare brand - selling products in the United States, Canada, the European Union and throughout Asia. To learn more, please visit the Company's website at www.reviv3.com and, for the AXIL® brand, visit www.axilbrands.com.
Forward-Looking Statements
This press release contains a number of forward-looking statements within the meaning of the federal securities laws. The use of words such as “believe,” “expect,” “continue,” “will,” “intends”, “prepare,” “should,” and ”focus,” among others, generally identify forward-looking statements. These forward-looking statements are based on currently available information, and management’s beliefs, projections, and current expectations, and are subject to a number of significant risks and uncertainties, many of which are beyond management’s control and may cause the Company’s results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things: (i) the Company’s ability to grow net sales as anticipated and perform in accordance with guidance; (ii) our ability to generate sufficient revenue to support the Company’s operations and to raise additional funds or obtain other forms of financing as needed on acceptable terms, or at all; (iii) potential difficulties or delays the Company may experience in implementing its cost savings and efficiency initiatives, including integrating the AXIL® brand; (iv) the Company’s ability to compete effectively with other hair and skincare companies and hearing enhancement and protection companies; (v) the concentration of the Company’s customers, potentially increasing the negative impact to the Company by changing purchasing or selling patterns; (vi) changes in laws or regulations in the United States and/or in other major markets, such as China, in which the Company operates, including, without limitation, with respect to taxes, tariffs, trade policies or product safety, which may increase the Company product costs and other costs of doing business, and reduce the Company’s earnings; and (vii) the impact of unstable market and general economic conditions on the Company’s business, financial condition and stock price, including inflationary cost pressures, the possibility of an economic recession and other macroeconomic factors, geopolitical events, and uncertainty, decreased discretionary consumer spending, supply chain disruptions and constraints, labor shortages, ongoing economic disruption, including the effects of the Ukraine-Russia conflict and the Israel-Hamas conflict, and other downturns in the business cycle or the economy. There can be no assurance as to any of these matters, and potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. Other important factors that may cause actual results to differ materially from those expressed in the forward-looking statements are discussed in the Company’s filings with the U.S. Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.
Investor Relations:
AXIL Investor Relations Team
(888) 638-8883
investors@axilbrands.com
FAQ
What is the new partnership announced by AXIL Brands (AXIL)?
Which AXIL products will be available through the Fuel Medical Group partnership?
How many affiliated locations does Fuel Medical Group have access to for AXIL products?
What benefits will Fuel Medical Group affiliates receive from the partnership with AXIL (AXIL)?
